معرفی
Esther de Haas is a researcher affiliated with the University Medical Center Groningen (UMCG) under the Faculty of Medical Sciences, contributing to the research groups Cure and Care in the Community Context (FOUR-C) and Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET). Her work intersects clinical research, pharmaceutical sciences, and geriatric care, with a focus on evidence-based practices in vulnerable populations.
- Primary Affiliation: Faculty of Medical Sciences, UMCG
- Research Groups: FOUR-C, PEGET
Research Interests
Esther de Haas specializes in PharmacoEpidemiology, analyzing drug effects and risks in real-world populations. Her research spans cardiovascular disease, dementia care, and geriatric pharmacology, with a focus on optimizing treatment protocols in nursing homes and addressing trial design challenges in clinical research.
Publication Trends
Her recent publications (2024–2021) emphasize systematic reviews, meta-epidemiological studies, and pharmacoepidemiological analyses, particularly in cardiovascular risk management and psychotropic drug use in dementia. Key topics include medication withdrawal, lipid-lowering therapy, and the impact of drug policies on trial outcomes.
Scientific Activities
- Professional Presentations: Delivered talks on cardiovascular medication in frail elderly (2024), cardiovascular risk management (2022), and preventive strategies in aging populations (2020).
- Peer Review: Reviewed for Drugs & Aging journal (2023).
- Event Organization: Co-organized sessions on preventive cardiovascular medication in older adults (2020).
Public Engagement
Contributed to public discourse on cholesterol management and evidence-based practices in diabetes and cardiovascular trials, including media appearances and peer-reviewed commentaries.
